Clinical Trials in MPNs 2026
- 7 hours ago
- 2 min read
As research in myeloproliferative neoplasms (MPNs) continues to evolve, clinical trials play a key role in shaping future treatment options. For patients, caregivers, and healthcare professionals, understanding these developments can help provide a clearer perspective on what is being explored and what may come next.
At the Global MPN Scientific Foundation, we aim to make this information more accessible by sharing expert-led webinars and educational content focused on current clinical trials.
Below, you will find a brief recap of some of the latest available sessions about the latest clinical trials in MPNs.
Content guide
Future and promising treatments for MF and CALR
In this insightful webinar, Prof. Haifa Al-Ali, hematologist and oncologist at the University Hospital of Halle (Germany), explores the future of treatment for patients living with myelofibrosis (MF).
The session focuses on emerging therapies and promising research related to CALR mutations, highlighting advances in targeted treatments and ongoing developments in the field.
These insights help provide a better understanding of how new treatment strategies may improve patient outcomes in the coming years.
New research in polycythemia vera: the divesiran clinical trial
A new webinar is now available exploring ongoing research in polycythemia vera (PV), with a focus on the divesiran clinical trial developed by Silence Therapeutics.
This session offers an accessible overview of innovative therapeutic approaches currently being studied in MPNs, helping to better understand how research is progressing in PV.
Access to clear and reliable information is essential to reduce uncertainty and support informed conversations with healthcare teams.
Latest updates on the POIESIS clinical trial for MF
This webinar features the latest insights into the POIESIS clinical trial, a study that is generating growing interest in the field of myelofibrosis (MF).
Dr. Pankit J. Vachhani, MD, from the O’Neal Comprehensive Cancer Center (United States), shares key updates on the trial, including its design, therapeutic approach, and the potential impact on future treatment options.
The session provides a valuable perspective on how ongoing clinical research may translate into new possibilities for patients living with MF.
Moving forward with knowledge: Clinical Trials in MPNs
Clinical trials represent an essential step in advancing the understanding and treatment of MPNs. While research is ongoing, having access to clear and accessible information can help patients feel more informed and supported throughout their journey.
We will continue to share updates, expert insights, and educational resources to bring research closer to the community.
Because understanding research is also part of living with MPN. 🌍